STAT14d
Sanofi is warned by the FDA over ‘significant’ problems at a key manufacturing plant
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts.
Sanofi’s Framingham facility hit with FDA warning
French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham.
dermatologyadvisor6d
FDA Warns Sanofi of Manufacturing Irregularities at Key Facility
The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.
Becker's Hospital Review13d
FDA warns Sanofi over manufacturing violations
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...
ENDPOINTS NEWS14d
Sanofi says no sup­ply in­ter­rup­tions af­ter land­ing FDA warn­ing let­ter for US site
A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in ...
Newport Dispatch9d
Framingham man arrested on gun, drug charges after police investigation
A 49-year-old man from Framingham was arrested following an investigation that led to the recovery of a firearm and drugs at ...
The Business Journals14d
Sanofi’s Framingham facility hit with FDA warning
For example, the FDA said about 20% of the bioreactor ... Sanofi (NYSE: SNY) acquired the Framingham facility when it bought Massachusetts-based Genzyme in a deal worth over $20 billion in 2011.
Yahoo11d
FDA Warns Sanofi of Manufacturing Irregularities at Key Facility
23—THURSDAY, Jan. 23, 2025 (HealthDay News) — The U.S. Food and Drug Administration has ... at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning ...